欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7249/001
药品名称Teriflunomid-ratiopharm 14 mg Filmtabletten
活性成分
    • Teriflunomide 14.0 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Teriflunomide Tifi 14 mg Filmtabletten
互认成员国 - 产品名称
    • Iceland (IS)
    • Cyprus (CY)
      Teriflunomide/Teva film-coated tablets, 14mg
    • France (FR)
    • Czechia (CZ)
      Teriflunomide Teva B.V.
    • Spain (ES)
    • Romania (RO)
    • Portugal (PT)
    • Slovakia (SK)
    • Italy (IT)
    • Croatia (HR)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Denmark (DK)
      Teriflunomide ”Teva”
    • Estonia (EE)
    • Netherlands (NL)
      Teriflunomide Teva 14 mg, filmomhulde tabletten
    • Hungary (HU)
      Teriflunomide Teva GmbH 14 mg filmtabletta
许可日期2022/11/15
最近更新日期2025/09/28
药物ATC编码
    • L04AA31 teriflunomide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase